770 related articles for article (PubMed ID: 29778671)
1. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design.
; Maron DJ; Hochman JS; O'Brien SM; Reynolds HR; Boden WE; Stone GW; Bangalore S; Spertus JA; Mark DB; Alexander KP; Shaw L; Berger JS; Ferguson TB; Williams DO; Harrington RA; Rosenberg Y
Am Heart J; 2018 Jul; 201():124-135. PubMed ID: 29778671
[TBL] [Abstract][Full Text] [Related]
2. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design.
Bangalore S; Maron DJ; Fleg JL; O'Brien SM; Herzog CA; Stone GW; Mark DB; Spertus JA; Alexander KP; Sidhu MS; Chertow GM; Boden WE; Hochman JS;
Am Heart J; 2018 Nov; 205():42-52. PubMed ID: 30172098
[TBL] [Abstract][Full Text] [Related]
3. Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial.
Hochman JS; Reynolds HR; Bangalore S; O'Brien SM; Alexander KP; Senior R; Boden WE; Stone GW; Goodman SG; Lopes RD; Lopez-Sendon J; White HD; Maggioni AP; Shaw LJ; Min JK; Picard MH; Berman DS; Chaitman BR; Mark DB; Spertus JA; Cyr DD; Bhargava B; Ruzyllo W; Wander GS; Chernyavskiy AM; Rosenberg YD; Maron DJ;
JAMA Cardiol; 2019 Mar; 4(3):273-286. PubMed ID: 30810700
[TBL] [Abstract][Full Text] [Related]
4. Impact of Chronic Kidney Disease on Outcomes of Myocardial Revascularization in Patients With Diabetes.
Farkouh ME; Sidhu MS; Brooks MM; Vlachos H; Boden WE; Frye RL; Hartigan P; Siami FS; Bittner VA; Chaitman BR; Mancini GBJ; Fuster V
J Am Coll Cardiol; 2019 Feb; 73(4):400-411. PubMed ID: 30704571
[TBL] [Abstract][Full Text] [Related]
5. Initial Invasive or Conservative Strategy for Stable Coronary Disease.
Maron DJ; Hochman JS; Reynolds HR; Bangalore S; O'Brien SM; Boden WE; Chaitman BR; Senior R; López-Sendón J; Alexander KP; Lopes RD; Shaw LJ; Berger JS; Newman JD; Sidhu MS; Goodman SG; Ruzyllo W; Gosselin G; Maggioni AP; White HD; Bhargava B; Min JK; Mancini GBJ; Berman DS; Picard MH; Kwong RY; Ali ZA; Mark DB; Spertus JA; Krishnan MN; Elghamaz A; Moorthy N; Hueb WA; Demkow M; Mavromatis K; Bockeria O; Peteiro J; Miller TD; Szwed H; Doerr R; Keltai M; Selvanayagam JB; Steg PG; Held C; Kohsaka S; Mavromichalis S; Kirby R; Jeffries NO; Harrell FE; Rockhold FW; Broderick S; Ferguson TB; Williams DO; Harrington RA; Stone GW; Rosenberg Y;
N Engl J Med; 2020 Apr; 382(15):1395-1407. PubMed ID: 32227755
[TBL] [Abstract][Full Text] [Related]
6. Conservative versus invasive stable ischemic heart disease management strategies: what do we plan to learn from the ISCHEMIA trial?
Cheng-Torres KA; Desai KP; Sidhu MS; Maron DJ; Boden WE
Future Cardiol; 2016 Jan; 12(1):35-44. PubMed ID: 26696561
[TBL] [Abstract][Full Text] [Related]
7. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction.
Anderson HV; Cannon CP; Stone PH; Williams DO; McCabe CH; Knatterud GL; Thompson B; Willerson JT; Braunwald E
J Am Coll Cardiol; 1995 Dec; 26(7):1643-50. PubMed ID: 7594098
[TBL] [Abstract][Full Text] [Related]
8. Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity.
Reynolds HR; Shaw LJ; Min JK; Page CB; Berman DS; Chaitman BR; Picard MH; Kwong RY; O'Brien SM; Huang Z; Mark DB; Nath RK; Dwivedi SK; Smanio PEP; Stone PH; Held C; Keltai M; Bangalore S; Newman JD; Spertus JA; Stone GW; Maron DJ; Hochman JS
Circulation; 2021 Sep; 144(13):1024-1038. PubMed ID: 34496632
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous Revascularization for Ischemic Ventricular Dysfunction: Rationale and Design of the REVIVED-BCIS2 Trial: Percutaneous Coronary Intervention for Ischemic Cardiomyopathy.
Perera D; Clayton T; Petrie MC; Greenwood JP; O'Kane PD; Evans R; Sculpher M; Mcdonagh T; Gershlick A; de Belder M; Redwood S; Carr-White G; Marber M;
JACC Heart Fail; 2018 Jun; 6(6):517-526. PubMed ID: 29852933
[TBL] [Abstract][Full Text] [Related]
10. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery.
Morrison DA; Sacks J
Minerva Cardioangiol; 2003 Oct; 51(5):585-97. PubMed ID: 14551526
[TBL] [Abstract][Full Text] [Related]
11. Strategies in stable ischemic heart disease: lessons from the COURAGE and BARI-2D trials.
Fernandez SF; Boden WE
Curr Atheroscler Rep; 2010 Nov; 12(6):423-31. PubMed ID: 20845088
[TBL] [Abstract][Full Text] [Related]
12. Medical Therapy Versus Revascularization in Patients with Stable Ischemic Heart Disease and Advanced Chronic Kidney Disease.
Paul TK; Mamas MA; Shanmugasundaram M; Nagarajarao HS; Ojha CP; Jneid H; Kumar G; White CJ
Curr Cardiol Rep; 2021 Mar; 23(4):23. PubMed ID: 33655382
[TBL] [Abstract][Full Text] [Related]
13. Death and Myocardial Infarction Following Initial Revascularization Versus Optimal Medical Therapy in Chronic Coronary Syndromes With Myocardial Ischemia: A Systematic Review and Meta-Analysis of Contemporary Randomized Controlled Trials.
Soares A; Boden WE; Hueb W; Brooks MM; Vlachos HEA; O'Fee K; Hardi A; Brown DL
J Am Heart Assoc; 2021 Jan; 10(2):e019114. PubMed ID: 33442990
[TBL] [Abstract][Full Text] [Related]
14. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
15. Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial.
Giustino G; Mehran R; Serruys PW; Sabik JF; Milojevic M; Simonton CA; Puskas JD; Kandzari DE; Morice MC; Taggart DP; Gershlick AH; Généreux P; Zhang Z; McAndrew T; Redfors B; Ragosta M; Kron IL; Dressler O; Leon MB; Pocock SJ; Ben-Yehuda O; Kappetein AP; Stone GW
J Am Coll Cardiol; 2018 Aug; 72(7):754-765. PubMed ID: 30092952
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of outcome and cost-effectiveness using an FDG PET-guided approach to management of patients with coronary disease and severe left ventricular dysfunction (PARR-2): rationale, design, and methods.
Beanlands R; Nichol G; Ruddy TD; deKemp RA; Hendry P; Humen D; Racine N; Ross H; Benard F; Coates G; Iwanochko RM; Fallen E; Wells G;
Control Clin Trials; 2003 Dec; 24(6):776-94. PubMed ID: 14662282
[TBL] [Abstract][Full Text] [Related]
17. Management of Coronary Disease in Patients with Advanced Kidney Disease.
Bangalore S; Maron DJ; O'Brien SM; Fleg JL; Kretov EI; Briguori C; Kaul U; Reynolds HR; Mazurek T; Sidhu MS; Berger JS; Mathew RO; Bockeria O; Broderick S; Pracon R; Herzog CA; Huang Z; Stone GW; Boden WE; Newman JD; Ali ZA; Mark DB; Spertus JA; Alexander KP; Chaitman BR; Chertow GM; Hochman JS;
N Engl J Med; 2020 Apr; 382(17):1608-1618. PubMed ID: 32227756
[TBL] [Abstract][Full Text] [Related]
18. Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise.
Stone GW; Hochman JS; Williams DO; Boden WE; Ferguson TB; Harrington RA; Maron DJ
J Am Coll Cardiol; 2016 Jan; 67(1):81-99. PubMed ID: 26616030
[TBL] [Abstract][Full Text] [Related]
19. Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia: Secondary Analysis of the ISCHEMIA Randomized Clinical Trial.
Reynolds HR; Shaw LJ; Min JK; Spertus JA; Chaitman BR; Berman DS; Picard MH; Kwong RY; Bairey-Merz CN; Cyr DD; Lopes RD; Lopez-Sendon JL; Held C; Szwed H; Senior R; Gosselin G; Nair RG; Elghamaz A; Bockeria O; Chen J; Chernyavskiy AM; Bhargava B; Newman JD; Hinic SB; Jaroch J; Hoye A; Berger J; Boden WE; O'Brien SM; Maron DJ; Hochman JS;
JAMA Cardiol; 2020 Jul; 5(7):773-786. PubMed ID: 32227128
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
